Pharmaceutical Manufacturing Report Summary

SIC Codes: 2833 2834 2835
NAICS Codes: 325411 325412 325413

Chapters Include

  • Industry Overview
  • Quarterly Industry Update
  • Business Challenges
  • Trends and Opportunities
  • Call Preparation Questions
  • Financial Information
  • Industry Forecast
  • Website and Media Links
  • Glossary of Acronyms

Pharmaceutical Manufacturing Industry Overview

Excerpt from Pharmaceutical Manufacturing Report

Companies in this industry manufacture and process pharmaceutical products. Major companies include Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Merck & Co, and Pfizer (all based in the US), as well as AstraZeneca (UK), Bayer (Germany), GlaxoSmithKline (UK), Novartis (Switzerland), Roche Holding (Switzerland), and Sanofi (France).

Competitive Landscape

Pharmaceutical manufacturers compete to discover and commercialize ever-more effective medicines. Companies focus on the most profitable markets, where demand for treatment is high. Key areas of development include cardiovascular, cancer, and diabetes medications, as increases in the number of elderly and obese patients fuel disease growth in these categories. Companies may also focus on rare disease categories, where available treatments are limited or nonexistent and opportunities exist for expedited approvals and profitable pricing.

Products, Operations & Technology

Traditional chemical pharmaceuticals (branded and generic) account for about 75% of industry revenue; biological (cell-based) drugs account for about 15%. Other products include in-vitro diagnostic substances, active pharmaceutical ingredients (APIs), and nutritional supplements.

Buy Now
Start Live ChatChat

*Required Fields

FREE Alerts to Changes in Your D&B® Credit Scores!* Sign Up. Get CreditSignal® for FREE!*
Try D&B Credit FREE for 30 Days! Get Started. Try D&B Credit FREE for 30 Days